Skip to main content
RUA LIFE SCIENCES PLC logo

RUA LIFE SCIENCES PLC — Investor Relations & Filings

Ticker · RUA ISIN · GB0033360586 LEI · 213800BMVB22PVOJ9Z28 IL Manufacturing
Open in API
Filings indexed 200 across all filing types
Latest filing 2018-07-20 Earnings Release
Country GB United Kingdom
Listing IL RUA

About RUA LIFE SCIENCES PLC

https://rualifesciences.com/

RUA Life Sciences is a medical device group focused on the application of its proprietary long-term implantable polymer, Elast-Eon™, a biostable polyurethane. The company operates through four integrated businesses to develop, manufacture, and license medical device solutions. RUA Biomaterials is responsible for licensing the Elast-Eon™ technology. RUA Medical provides end-to-end contract development and manufacturing services, specializing in implantable fabrics. RUA Vascular develops large-bore, polymer-sealed vascular grafts and soft tissue patches. RUA Structural Heart is engaged in the development of next-generation tri-leaflet polymeric heart valves. The group's collective mission is to improve patient outcomes by enabling and enhancing medical devices through its advanced polymer technology.

Recent filings

Filing Released Lang Actions
Final Results
Earnings Release Classification · 1% confidence The document is an announcement of 'Final results for the year ended 31 March 2018' for AorTech International PLC. It contains a Chairman's Statement, highlights, financial performance summaries, and strategic updates. While it provides financial data, it is presented as an 'RNS' (Regulatory News Service) announcement, which is the standard format for UK-listed companies to release their annual results to the market. According to the 'Menu vs Meal' rule, this is the announcement of the results rather than the full, multi-page statutory Annual Report document itself. Therefore, it is classified as an Earnings Release (ER). FY 2018
2018-07-20 English
New Patent Issued
Regulatory Filings Classification · 1% confidence The document is a short announcement regarding the issuance of a new patent in Brazil for AorTech International PLC. It is distributed via the Regulatory News Service (RNS) of the London Stock Exchange. Since it does not fit into specific categories like financial reports, dividends, or M&A, and is a general corporate regulatory announcement, it falls under the RNS category.
2018-07-04 English
Development and Supply Agreement with RUA Medical
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from the London Stock Exchange regarding a 'Development and Supply Agreement' between AorTech International PLC and RUA Medical. It describes a specific business partnership and operational development rather than a financial report, dividend, or management change. Since it does not fit into the specific categories like M&A (which usually implies a takeover or merger of entities) or other specialized categories, it falls under the general regulatory filing category.
2018-06-28 English
Development Agreement Signed
Regulatory Filings Classification · 1% confidence The document is a regulatory news announcement (RNS) issued by AorTech International PLC regarding the signing of a Development Agreement with Vascular Flow Technologies Limited. It describes a business partnership and project development rather than financial results, dividends, or governance changes. As it is a standard corporate announcement distributed via the London Stock Exchange's RNS service, it falls under the 'Regulatory Filings' category.
2018-06-19 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings'. It explicitly details a change in voting rights for AorTech International PLC, identifying a shareholder (W B Nominees Limited) crossing a specific threshold (12.96%). This matches the definition for 'Major Shareholding Notification' (MRQ).
2018-06-15 English
Result of GM and TVR
Regulatory Filings Classification · 1% confidence The document is an RNS announcement from AorTech International PLC titled 'Result of General Meeting and Total Voting Rights'. It confirms that resolutions were passed at a General Meeting and provides details on new share admissions and the resulting total voting rights. While it mentions voting results, the primary regulatory function of this specific filing is to announce the outcome of a meeting and the subsequent change in share capital/voting rights. Given the dual nature of reporting voting results and share capital changes, 'DVA' (Declaration of Voting Results) is the most specific fit for the 'Result of General Meeting' aspect, which is the primary headline.
2018-06-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.